NCT00408031View on ClinicalTrials.gov

D-cycloserine for Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Major Depressive Disorder
Interventions
DRUG

D-cycloserine

D-cycloserine (DCS , Seromycin) is a broad spectrum antibiotic, in use for over thirty years against tuberculosis, that acts as a partial agonist at the NMDAR-associated GLY site.

Trial Locations (2)

Unknown

Ezrath Nashim - Herzog Memorial Hospital & Community Clinics, Jerusalem

Ezrath Nashim - Herzog Memorial Hospital, Jerusalem

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Herzog Hospital

OTHER

NCT00408031 - D-cycloserine for Major Depressive Disorder | Biotech Hunter | Biotech Hunter